Malignancy
90
17
20
36
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.6%
5 terminated out of 90 trials
87.8%
+1.3% vs benchmark
8%
7 trials in Phase 3/4
22%
8 of 36 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 36 completed trials
Clinical Trials (90)
Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity
Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Using an Artificial Intelligence Medical Device to Help Primary Care Practitioners Identify and Manage Skin Conditions (Tumor, Inflammatory, and Infectious Diseases) in Adult Patients at Pozuelo and Majadahonda Health Centers
Validation Study of Pediatric Patient-Reported Outcomes
Pilot Study Evaluating Tumor Microenvironment Interaction in Solid Tumor Patients
Chest Wall Reconstruction Cohort
Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T Cells
Target-specific immunoPET Imaging of Digestive System Carcinoma
Abatacept as GVHD Prophylaxis Phase 2
Community Health Worker Based Intervention to Improve Palliative Care
DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.
DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition
DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations
Immuno-Oncology Database and Bioregistry
Evaluation of the Effectiveness of Prophylactic LMWH by Thromboelastography
Tandem Polyurethane Stents Compared to Single Silicone Stent for Malignant Ureteral Obstruction
Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository
Assessment of the Impact of Increased Production of Reactive Oxygen Species Produced During Repeated Sessions of Hyperbaric Oxygen Therapy in Patients Undergoing Radiotherapy for Neoplasia, on the Occurrence of DNA Damage
The Role of Stereo-tActic BoDy RadIotherApy iN Oligo-Progressive MalignanT Disease